Drug Trial Radar · NCT02465567
Study to Assess the Efficacy and Safety of PT010 Relative to PT003 and PT009 in Subjects With Moderate to Very Severe COPD (Ethos)
Last checked: Nov 19, 2026Latest source record: Feb 2, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
8,588
Actual
Start
Jun 30, 2015
Primary completion
Jul 26, 2019
Study completion Jul 26, 2019
Sponsor
- Lead sponsor
- Pearl Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jun 8, 2015
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, multi-center, parallel-group study to assess the efficacy and safety of PT010 relative to PT003 and PT009 on COPD exacerbations subjects with moderate to very severe COPD.
Conditions
- COPD
Interventions
BGF MDI 320/14.4/9.6 μgDrug
Budensonide, Glycopyrronium, and Formoterol Fumarate
GFF MDI 14.4/9.6 μgDrug
Glycopyrronium, and Formoterol Fumarate
BGF MDI 160/14.4/9.6 μgDrug
Budensonide, Glycopyrronium, and Formoterol Fumarate
BFF MDI 320/9.6 μgDrug
Budensonide, and Formoterol Fumarate
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adjusted Rate of Moderate or Severe ExacerbationsTime frame: 52-week treatment period
Locations
741 sites in 26 countries. Site status is shown where the registry gives one.
Research Site
Andalusia, Alabama
Research Site
Athens, Alabama
Research Site
Birmingham, Alabama
Research Site
Birmingham, Alabama
Research Site
Birmingham, Alabama
Research Site
Dothan, Alabama
Research Site
Florence, Alabama
Research Site
Foley, Alabama
Research Site
Gulf Shores, Alabama
Research Site
Jasper, Alabama
Research Site
Mobile, Alabama
Research Site
Montgomery, Alabama
Research Site
Scottsboro, Alabama
Research Site
Sheffield, Alabama
Research Site
Peoria, Arizona
Research Site
Phoenix, Arizona
Research Site
Phoenix, Arizona
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Conway, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Little Rock, Arkansas
Research Site
North Little Rock, Arkansas
Research Site
Bakersfield, California
Research Site
Beverly Hills, California
Research Site
Cerritos, California
Research Site
El Cajon, California
Research Site
Escondido, California
Research Site
Fresno, California
Research Site
Gold River, California
Research Site
Hawaiian Gardens, California
Research Site
Huntington Beach, California
Research Site
Huntington Park, California
Research Site
La Mirada, California
Research Site
Lakewood, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Showing 40 of 741 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.